Skip to Content

M CL2 (Carbidopa and Levodopa 25 mg / 100mg)

Pill with imprint M CL2 is Yellow, Round and has been identified as Carbidopa and Levodopa 25 mg / 100mg. It is supplied by Mylan Pharmaceuticals Inc..

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M CL2

Carbidopa and Levodopa

Imprint:
M CL2
Strength:
25 mg / 100mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
crospovidone
hydroxypropyl cellulose (type h)
magnesium stearate
microcrystalline cellulose
corn starch
D&C Yellow No. 10
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0884 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide